OpenAI’s new o1 Series models focus on enhanced reasoning, presenting opportunities for life sciences and healthcare. Abid Rahman explores how these capabilities could support medical research, clinical decision-making, and complex problem-solving in pharma marketing, driving innovation across the industry.
October 3, 2024
OpenAI’s New o1 Series Models’ Focus on “Reasoning” and What It Could Mean to Lifesciences Brands and Marketers
